Ocugen (OCGN) EBITDA Margin (2014 - 2026)
Ocugen (OCGN) reported EBITDA Margin of 1257.66% for Q1 2026, down 22066.0% on a YoY basis from N/an in Q1 2025, and down 113.71% quarter-over-quarter from 9172.54% in Q4 2025.
Ocugen (OCGN) EBITDA Margin (2014 - 2026) Analysis & Trends
Ocugen has reported EBITDA Margin for 7 years, with the latest figure at 1257.66% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 22066.0% year-over-year to 1257.66%; the trailing twelve-month figure through Mar 2026 stood at 1607.05% (down 33627.0% YoY), and the FY2025 full-year result was 1537.12%, down 20479.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 1257.66%, down from 9172.54% in the prior quarter.
- The five-year high for EBITDA Margin was 9172.54% in Q4 2025, with the low at 5127.25% in Q3 2022.
- Historically, EBITDA Margin has averaged 1493.56% across 5 years, with a median of 1257.66% in 2026.
- Annual changes were most pronounced in 2023 — EBITDA Margin tumbled 141694 bps — and 2025, when it soared 1098602 bps.
- Ocugen's EBITDA Margin stood at 2548.12% in 2022, then surged by 69 bps to 779.06% in 2023, then tumbled by 133 bps to 1813.48% in 2024, then jumped by 606 bps to 9172.54% in 2025, then plunged by 114 bps to 1257.66% in 2026.
- The last three EBITDA Margin figures came in at 1257.66% (Q1 2026), 9172.54% (Q4 2025), and 1141.84% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | -1,257.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,257.66% |
| Dec 31, 2025 | 9,172.54% |
| Sep 30, 2025 | -1,141.84% |
| Jun 30, 2025 | -1,075.53% |
| Mar 31, 2025 | -1,037.00% |
| Dec 31, 2024 | -1,813.48% |
| Sep 30, 2024 | -1,142.17% |
| Jun 30, 2024 | -1,338.91% |
| Mar 31, 2024 | -1,175.44% |
| Dec 31, 2023 | -779.06% |
| Sep 30, 2023 | -316.63% |
| Jun 30, 2023 | -4,756.29% |
| Mar 31, 2023 | -3,911.29% |
| Dec 31, 2022 | -2,548.12% |
| Sep 30, 2022 | -5,127.25% |
| Jun 30, 2022 | -3,339.35% |
| Mar 31, 2022 | -3,803.00% |
| Jun 30, 2020 | -8,404.65% |
| Sep 30, 2014 | -2.30% |